Impact of atrial prevention pacing on atrial fibrillation burden: Primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial

Heart Rhythm

Volumn 6, Issue 3, 2009, Pages 295-301

  Gold, Michael R ^a   Adler, Stuart ^b   Fauchier, Laurent ^c   Haffajee, Charles ^d   Ip, John ^e   Kainz, Walter ^f   Kawasaki, Raymond ^g   Prakash, Atul ^h   Táborský, Miloš ⁱ   Waller, Theodore ^j   Wilson, Vance ^k   Li, Shelby ^l   Hoffmann, Ellen ^m  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b St Paul Heart Clinic   (United States)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

^e Ingham Regional Medical Center   (United States)

^f HANUSCH HOSPITAL   (Austria)

^g Midwest Heart Research Foundation   (United States)

^h ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

ⁱ NA HOMOLCE HOSPITAL   (Czech Republic)

^j The Carl & Edyth Lindner Center for Research & Education   (United States)

^k Daytona Heart Group   (United States)

^l MEDTRONIC INC   (United States)

^m Munich Municipal Hospital   (Germany)

more..

Author keywords

Arrhythmia; Atrial fibrillation; Pacing; Prevention

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIURETIC AGENT;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART VENTRICLE PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; THERAPY EFFECT;

AGED; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL;

EID: 60749130257     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.11.033     Document Type: Article

References (26)

1. Lamas G.A., Lee K.L., Sweeney M.O., et al., Mode Selection Trial in Sinus Node Dysfunction Investigators. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 346 (2002) 1854-1862
2. Kerr C.R., Connolly S.J., Abdollah H., et al., Canadian Trial of Physiological Pacing (CTOPP) Investigators. Canadian Trial of Physiologic Pacing: effects of physiologic pacing during long-term follow-up. Circulation 109 (2004) 357-362
3. Connolly S.J., Kerr C.R., Gent M., et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 342 (2000) 1385-1391
4. Andersen H.R., Nielsen J.C., Thomsen P.E., et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 350 (1997) 1210-1216
5. Delfaut P., Saksena S., Prakash A., et al. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single-and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 32 (1998) 1900-1908
6. Lamas G.A., Orav E.J., Stambler B.S., et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 338 (1998) 1097-1104
7. Blanc J.J., De Roy L., Mansourati J., et al., PIPAF Investigators. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 6 (2004) 371-379
8. Lee M.A., Weachter R., Pollak S., et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 41 (2003) 1926-1932
9. Padeletti L., Purerfellner H., Adler S.W., et al., Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 14 (2003) 1189-1195
10. Levy T., Walker S., Rex S., et al. Does atrial overdrive pacing prevent paroxysmal atrial fibrillation in paced patients?. Int J Cardiol 75 (2000) 91-97
11. Lozano I.F., Vincent A., Roda J., et al. Paroxysmal atrial fibrillation prevention by pacing in patients with pacemaker indication. Europace 5 (2003) 267-273
12. Israel C.W., and Hohnloser S.H. Pacing to prevent atrial fibrillation. J Cardiovasc Electrophysiol 14 9 Suppl (2003) S20-S26
13. Carlson M.D., Ip J., Messenger J., et al. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 42 (2003) 627-633
14. Knight B.P., Gersh B.J., Carlson M.D., et al., AHA Writing Group. Role of permanent pacing to prevent atrial fibrillation: science advisory from the AHA Council on Clinical Cardiology and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 111 (2005) 240-243
15. Savelieva I., and Camm A.J. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough?. J Interv Card Electrophysiol 8 (2003) 103-115
16. Gold M.R., and Hoffmann E. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI). Am Heart J 152 (2006) 231-236
17. Mitchell A.R.J., and Sulke N. How do atrial pacing algorithms prevent atrial arrhythmias?. Europace 6 (2004) 351-362
18. Carlioz R., Perrier E., Thomas O., et al. Accuracy of atrial tachyarrhythmia monitoring in the Selection device: correlation with an external Holter recording. In: Thomsen P.E.B. (Ed). Europace 2001 (2001), Monduzzi Editore S.p.A.-Medimond, Inc, Bologna, Italy 419-423
19. Hettrick D.A., Orlov M.V., Ghali J., et al. Bi-modal distribution of atrial tachyarrhythmia burden in the pacemaker population: are traditional statistical analyses of arrhythmia recurrence valid?. Heart Rhythm 2 (2005) S282
20. Conover W.J., and Iman R.L. Rank transformation as a bridge between parametric and nonparametric statistics. Am Stat 35 (1981) 124-134
21. Sweeney M.O., Helkamp A.S., Ellenbogen K.A., et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107 (2003) 2932-2937
22. Mehra R., Ziegler P., and Koehler J. Diagnostic information in implantable devices that pertains to endpoints in atrial fibrillation studies. Heart Rhythm 1 (2004) B64-B69
23. Sweeney M.O., Bank A.J., Nsah E., et al. Minimizing ventricular pacing to reduce AF in sinus-node disease. N Engl J Med 357 (2007) 1000-1008
24. Hoffmann E., Sulke E., Edvardsson N., et al., Atrial Fibrillation Therapy (AFT) Trial Investigators. New Insights into the initiation of atrial fibrillation. A detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation 113 (2006) 1933-1941
25. Allessie M., Boyden P., Camm J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 103 (2001) 769-777
26. Healey J.S., Toff W.D., Lamas G.A., et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation 114 (2006) 11-17